Publication:
Evidence that the novel receptor FGFRL1 signals indirectly via FGFR1

cris.virtual.author-orcid0000-0001-8684-6856
cris.virtualsource.author-orcidaf333801-30e1-4688-9650-d09787ec14c3
cris.virtualsource.author-orcid0df3e1c7-3e8f-4785-8afd-a634d3a35baf
datacite.rightsopen.access
dc.contributor.authorAmann, Ruth
dc.contributor.authorTrueb, Beat
dc.date.accessioned2024-10-14T16:07:26Z
dc.date.available2024-10-14T16:07:26Z
dc.date.issued2013-11
dc.description.abstractFibroblast growth factor (FGF) receptor-like protein 1 (FGFRL1) is a recently discovered member of the FGF receptor (FGFR) family. Similar to the classical FGFRs, it contains three extracellular immunoglobulin-like domains and interacts with FGF ligands. However, in contrast to the classical receptors, it does not contain any intracellular tyrosine kinase domain and consequently cannot signal by transphosphorylation. In mouse kidneys, FgfrL1 is expressed primarily at embryonic stages E14-E15 in regions where nascent nephrons develop. In this study, we used whole-mount in situ hybridization to show the spatial pattern of five different Fgfrs in the developing mouse kidney. We compared the expression pattern of FgfrL1 with that of other Fgfrs. The expression pattern of FgfrL1 closely resembled that of Fgfr1, but clearly differed from that of Fgfr2‑Fgfr4. It is therefore conceivable that FgfrL1 signals indirectly via Fgfr1. The mechanisms by which FgfrL1 affects the activity of Fgfr1 remain to be elucidated.
dc.description.numberOfPages6
dc.description.sponsorshipUniversitätsklinik für Rheumatologie, klinische Immunologie und Allergologie
dc.description.sponsorshipUniversitätsklinik für Rheumatologie, klinische Immunologie und Allergologie, Teilklinik Rheumatologie
dc.identifier.doi10.7892/boris.42840
dc.identifier.pmid24026051
dc.identifier.publisherDOI10.3892/ijmm.2013.1484
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/114148
dc.language.isoen
dc.publisherSpandidos Publications
dc.relation.ispartofInternational journal of molecular medicine
dc.relation.issn1107-3756
dc.relation.organizationDCD5A442BE23E17DE0405C82790C4DE2
dc.relation.organizationDCD5A442BAD8E17DE0405C82790C4DE2
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleEvidence that the novel receptor FGFRL1 signals indirectly via FGFR1
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage988
oaire.citation.issue5
oaire.citation.startPage983
oaire.citation.volume32
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, klinische Immunologie und Allergologie
oairecerif.author.affiliationUniversitätsklinik für Rheumatologie, klinische Immunologie und Allergologie, Teilklinik Rheumatologie
unibe.contributor.rolecreator
unibe.contributor.rolecreator
unibe.description.ispublishedpub
unibe.eprints.legacyId42840
unibe.journal.abbrevTitleINT J MOL MED
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
ijmm-32-05-0983.pdf
Size:
642.59 KB
Format:
Adobe Portable Document Format
File Type:
text
License:
publisher
Content:
published

Collections